FGvW advises Bentley InnoMed GmbH on medtech deal with Upstream Peripheral Technologies

Bentley InnoMed GmbH has obtained the rights to an innovative medical device, the so-called GoBack catheter, in a complex asset deal. At the same time, Bentley InnoMed GmbH has entered into a comprehensive cooperation agreement with the Israeli company Upstream Peripheral Technologies Ltd. regarding the manufacture of the GoBack catheter. In the transaction, Bentley InnoMed GmbH was legally advised by our M&A team led by our partner Meike Kapp-Schwoerer.

The GoBack catheter will simplify the “cross” and/or “re-entry” lesions in the arteries, which are for example occluded by heavily calcified plaque or stenosis.

Because of its slim profile, the product can even be used in the smaller arteries in the lower leg. Initially, the product will continue to be manufactured in Israel. It is planned to transfer production to the Bentley InnoMed GmbH plant in Hechingen in 2025.

Bentley InnoMed GmbH was founded in 2009 by two medical entrepreneurs, Lars Sunnanväder and Miko Obradovic. Based in Hechingen, Germany, Bentley InnoMed GmbH has grown significantly since launching its first product in 2012 and now maintains a global distribution network in more than 80 countries.

Upstream Peripheral Technologies Ltd. developed and manufactures the GoBack catheter for the treatment of chronic total occlusions in angioplasty (treatment of narrowed blood vessels) and is a subsidiary of the publicly traded ARAN Group.

We advised Bentley InnoMed GmbH together with the Israeli law firm Herzog, Fox & Neeman as well as Kegler + Brown, Ohio/USA.

Advisors to Bentley InnoMed GmbH:

Meike Kapp-Schwoerer, partner (lead, M&A, medical device law)
Jan Henning Martens, Partner (M&A, Medical Device Law)
Lukas Kalkbrenner, Partner (IP)
Maximilian Fessel (Associate)

Contact: